Comparison of PDE 4 Inhibitors, Rolipram and SB 207499 (Ariflo^TM, in a Rat Model of Pulmonary Neutrophilia

By Spond J.   Chapman R.   Fine J.   Jones H.   Kreutner W.   Kung T.T.   Minnicozzi M.  

Pulmonary Pharmacology & Therapeutics, Vol. 14, Iss. 2, 2001-03 ,pp. : 157-164

Academic Press

Access to resources Recommend Favorite

Ariflo^TM(SB 207499), a Second Generation Phosphodiesterase 4 Inhibitor for the Treatment of Asthma and COPD: from Concept to Clinic

By Torphy T.J.   Barnette M.S.   Underwood D.C.   Griswold D.E.   Christensen S.B.   Murdoch R.D.   Nieman R.B.   Compton C.H.  

Pulmonary Pharmacology & Therapeutics, Vol. 12, Iss. 2, 1999-04 ,pp. : 131-135

Academic Press

Access to resources Recommend Favorite

Bronchodilatory and anti-inflammatory properties of inhaled selective phosphodiesterase inhibitors in a guinea pig model of allergic asthma

By Santing R.E.   de Boer J.   Rohof A.   van der Zee N.M.   Zaagsma J.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 335-344

Elsevier

Access to resources Recommend Favorite

Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease

By Spina D.  

Drugs, Vol. 63, Iss. 23, 2003-01 ,pp. : 2575-2594

Adis International

Access to resources Recommend Favorite

Highly Selective Phosphodiesterase 4 Inhibitors for the Treatment of Allergic Skin Diseases and Psoriasis

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 6, Iss. 1, 2007-03 ,pp. : 17-26

Bentham Science Publishers

Access to resources Recommend Favorite